Brookfield Corp’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Brookfield Corp’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-50,000	Closed	-$316K	–	829
2022 Q4	$316K	Buy	+50,000	New	+$277K	﹤0.01%	557

Brookfield Corp's FSTX Position: Q1 2023 in Review

Brookfield Corp sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 50,000 shares — an estimated $316K sold.

Brookfield Corp first reported a position in FSTX in Q4 2022 and held it in 1 quarter. The position peaked at $316K in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Brookfield Corp reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Brookfield Corp sold 50,000 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $316K.
Brookfield Corp first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Brookfield Corp's F-star Therapeutics, Inc. Common Stock position peaked at $316K in Q4 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Brookfield Corp's 13F filing for Q1 2023, filed 15 May 2023.